Ọkwa ọgwụ 209216-23-9 Entecavir Monohydrate Maka Ọgwụgwọ ịba ọcha n'anya B
| Ngwaahịaaha | Entecavir monohydrate |
| Ụdị okwu | 2-Amino-1,9-dihydro-9-[(1S,3R,4S) -4-hydroxy-3- (hydroxymethyl) -2-methylenecyclopentyl]-6H-purin-6-otu monohydrate. |
| CAS Mba. | 209216-23-9 |
| Ọdịdị | Na-acha ọcha na-acha ọcha ntụ ntụ |
| Usoro ihe omimi | C12H15N5O3.H2O |
| Ibu molekụla | 295.30 |
| Ojiji | Ọkwa ọgwụ ma ọ bụ ebumnuche nyocha |
| Nkwakọ ngwaahịa | Dị ka arịrịọ gị si dị |
| Nchekwa | Chekwaa n'ime akpa siri ike, nke na-enweghị ọkụ n'ebe dị mma |
| Entecavir monohydrate Cas: 209216-23-9 | ||
| Ihe | Ọkọlọtọ | Nsonaazụ |
| Ọdịdị | Na-acha ọcha na-acha ọcha ntụ ntụ | Na-akwado |
| Ntụgharị anya | +24.0°—+28.0°(DMF:MeOH=1:1 c=1%) | +27.0° |
| njirimara | A: Site IR, Iji dakọtara na ọkọlọtọ ọrụ | Na-akwado |
| B: Site na HPLC, njide oge kwesịrị dakọtara na ọkọlọtọ ọrụ | Na-akwado | |
| Mmiri | 5.8% - 6.5% | 6.1% |
| Isomer | Otu ≤0.1% | 0.02% |
| Ngụkọta ≤0.5% | 0.02% | |
| Ihe ndị emetụtara | Otu adịghị ọcha ≤0.1% | 0.05% |
| Mkpokọta adịghị ọcha ≤0.3% | 0.07% | |
| Ihe fọdụrụ na mgbanye | ≤0.1% | 0.04% |
| Ọla dị arọ | £10ppm | Na-akwado |
| Ihe mgbaze fọdụrụnụ | Kwesịrị dabara na ọkọlọtọ | Na-akwado |
| Nyocha | ≥99.8% | 99.9% |
| Mmechi:Na-agbaso ụkpụrụ ụlọ. | ||
Ozi ụlọ ọrụ
√ Ahụmahụ zuru oke nke oyi akwa na ụlọ ọrụ mmepụta ihe na ndị na-eso ụzọ teknụzụ nwere nkà; √ Quality bụ mgbe anyị n'elu echiche, siri ike QC usoro; √ 11 afọ nwere ahụmahụ mbupụ ahịa otu; √ ụlọ nyocha R&D nọọrọ onwe ya; √ Ụlọ ọrụ GMP abụọ bịanyere aka na ogologo oge; √ Akụ bara ụba nke ọtụtụ ụlọ ọrụ na-abaghị uru maka ọrụ ahaziri iche; √ Ndị otu na-arụ ọrụ nke ọma na ụzọ na-agbanwe agbanwe.
Dee ozi gị ebe a ziga anyị ya
